Vanda Pharmaceuticals (VNDA) Other Working Capital Changes (2016 - 2025)
Vanda Pharmaceuticals' Other Working Capital Changes history spans 16 years, with the latest figure at $5.9 million for Q4 2025.
- On a quarterly basis, Other Working Capital Changes rose 63.43% to $5.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.1 million, a 77.04% increase, with the full-year FY2025 number at $12.1 million, up 77.04% from a year prior.
- Other Working Capital Changes hit $5.9 million in Q4 2025 for Vanda Pharmaceuticals, up from -$703000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for VNDA hit a ceiling of $13.4 million in Q1 2022 and a floor of -$11.3 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged $887150.0 across 5 years, with a median of $1.3 million in 2021.
- The widest YoY moves for Other Working Capital Changes: up 26820.0% in 2022, down 398.11% in 2022.
- Tracing VNDA's Other Working Capital Changes over 5 years: stood at -$1.7 million in 2021, then tumbled by 104.57% to -$3.4 million in 2022, then tumbled by 108.59% to -$7.2 million in 2023, then skyrocketed by 150.58% to $3.6 million in 2024, then soared by 63.43% to $5.9 million in 2025.
- Business Quant data shows Other Working Capital Changes for VNDA at $5.9 million in Q4 2025, -$703000.0 in Q3 2025, and $1.4 million in Q2 2025.